跳至主要内容
临床试验/ISRCTN67123277
ISRCTN67123277已完成不适用

Circadian intraocular pressure, blood pressure and diastolic ocular perfusion pressure with timolol-dorzolamide fixed combination compared with latanoprost in newly-diagnosed glaucoma patients

Clinica Oculistica (Italy)0 个研究点目标入组 27 人开始时间: 2007年8月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • We enrolled in the present study consecutive newly diagnosed and previously untreated POAG patients who demonstrated typical optic disc excavation and visual field abnormalities. We included POAG patients older than 45 years with no previous history of ocular surgery or laser. Additional inclusion criteria were:
  • 1. Open-angle by gonioscopy (Grade III-IV according to Shaffer?s grading system)
  • 2. Untreated diurnal IOP between 23 and 32 mm Hg (mean of the two highest values recorded in a daytime IOP curve with measurements every 2 hours between 08:00 and 18:00 by a calibrated Goldmann applanation tonometry)
  • 3. Visual acuity 20/40 or better
  • 4. Mean defect >6 dB using the Humphrey 24-2 program (Humphrey Visual Field Analyzer model 745 perimeter, Humphrey Instruments, Inc., USA)
  • 5. No history of allergy to the ingredients of any of the study drugs
  • 6. No history of cardiovascular disease (e.g. arterial hypertension, heart disease, arrhythmia)
  • 7. No concomitant systemic treatment (e.g. beta-blockers, angiotensin-converting enzyme inhibitors) that could modify IOP, or blood pressure.
  • 8. Females were enrolled in the study only if they were postmenopausal or were using contraceptives

排除标准

  • See inclusion criteria

研究者

发起方
Clinica Oculistica (Italy)

相似试验

Circadian intraocular pressure, blood pressure and... | 临床试验